Lingaraj Nayak
Mumbai, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications
Enabling access to talicabtagene autoleucel in relapsed/refractory B-cell malignancies; multicenter real-world evidence on delivery, efficacy and safety.
Journal: Blood cancer journal
Published: February 24, 2026
Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML.
Journal: JCO global oncology
Published: February 20, 2026
Risk of Hepatitis B Reactivation Among ALL Patients With Occult Hepatitis B Infection.
Journal: JCO global oncology
Published: January 23, 2026
TGFβ-Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic Leukemia.
Journal: Molecular carcinogenesis
Published: January 15, 2026
Venetoclax induces mitochondrial apoptosis and autophagy to overcome arsenic trioxide resistance in acute promyelocytic leukemia.
Journal: Journal of translational medicine
Published: December 17, 2025
Acute myeloid leukaemia (AML) harbouring KMT2A-PTD: should it be considered as a myelodysplasia-related abnormality?
Journal: Journal of clinical pathology
Published: October 01, 2025
MRD Directed Consolidation in Multiple Myeloma-Are We There Yet?
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 22, 2025
Treatment free remission (TFR) in chronic myeloid leukemia-results, compliance and patterns of failure from a tertiary care cancer centre in India.
Journal: Blood cancer journal
Published: July 22, 2025
Is Less "Sufficient" and "Safe" in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma.
Journal: Blood cancer journal
Published: June 28, 2025
Last Updated: 09/26/2026